GoodRx Holdings, Inc.

GoodRx Holdings, Inc. (GDRX) priced its initial public offering on Sep 24, 2020 at $33.00 per share, above its $24.00–$28.00 range, raising $1.14B, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.24B. Morgan Stanley was lead-left underwriter, joined by Goldman Sachs, J.P. Morgan and Barclays and others. Latham & Watkins and Whalen advised the company and Davis Polk advised the underwriters.

GoodRx Holdings, Inc. is building a consumer-focused digital healthcare platform in the United States. Its stated mission is to help Americans get the healthcare they need at a price they can afford, in the face of rising costs, higher deductibles and care restrictions.

Status

IPO

Ticker

GDRX

Exchange

Nasdaq Global Select

Priced

Sep 24, 2020

IPO price

$33.00

Price range

$24.00–$28.00

Raised

$1.14B

Market cap at IPO price

$1.24B

First filed

Aug 28, 2020

Underwriters

Morgan Stanley, Goldman Sachs, J.P. Morgan, Barclays, BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS, TD Cowen, Deutsche Bank and Evercore ISI

Company counsel

Latham & Watkins and Whalen

Underwriters' counsel

Davis Polk

Sector

Technology

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.